Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies.
OBJECTIVE: To test whether the chronic relapsing arthritis induced by immunizing DBA/1 mice with homologous type II collagen is a valuable model for testing disease-modifying antiarthritic drugs. METHODS: Six-week-old male DBA/1 mice were immunized with murine type II collagen in Freund's compl...
Main Authors: | Malfait, A, Williams, R, Malik, A, Maini, R, Feldmann, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA/1 mice partly through the suppression of tumour necrosis factor.
by: Sumariwalla, P, et al.
Published: (2004) -
Combination therapy with DMARDs and biological agents in collagen-induced arthritis.
by: Williams, R, et al.
Published: (1999) -
Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis.
by: Malfait, A, et al.
Published: (1998) -
The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action.
by: Malfait, A, et al.
Published: (1999) -
Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis.
by: Butler, D, et al.
Published: (1999)